MIRA INFORM REPORT
|
Report Date : |
27.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
COHERENT GMBH |
|
|
|
|
Registered Office : |
Hans-Bockler-Strasse 12, Gottingen, 37079 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
30.09.2010 |
|
|
|
|
Date of Incorporation : |
06.07.2005 |
|
|
|
|
Legal Form : |
Private Subsidiary |
|
|
|
|
Line of Business : |
Scientific and Technical Instruments |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Germany |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
Coherent GmbH
Hans-Bockler-Strasse 12
Gottingen, 37079
Germany
Tel: +49 (0) 551 69380
Fax: +49 (0) 551 68691
Web: www.coherent.de
Synthesis
Employees: 365
Company Type: Private Subsidiary
Corporate Family: 2
Companies
Ultimate Parent: Coherent Holding GmbH
Incorporation Date:
06-Jul-2005
Financials in: USD (Millions)
Fiscal Year End:
30-Sep-2009
Reporting Currency: Euro
Annual Sales: 127.5
Total Assets: 174.8
Business Description
In the highly
sophisticated industry of photonics, Coherent leads the way, offering
reliability, cost, and performance advantages for the widest range of
commercial and scientific research applications. Founded in 1966, Coherent has
production and research facilities spanning the world, supplying everything
from laser systems and components to laser measurement and control products and
precision optics to over 80 countries. Notably, many of its customers are
Fortune 500 leading manufacturers and scientific researchers from numerous
universities and institutes across the Americas, Europe, and Pacific Rim.
Markets for Coherent's products include microelectronics (which includes
semiconductor test and measurement, flat panel display manufacturing, and
advanced packaging), scientific research and government programs, materials
processing, OEM components and instrumentation (which includes such areas as
biotechnology, medical imaging and treatment), and graphic arts and display.
Industry
Industry Scientific and Technical
Instruments
ANZSIC 2006: 2419 - Other
Professional and Scientific Equipment Manufacturing
NACE 2002: 3340 - Manufacture
of optical instruments and photographic equipment
NAICS 2002: 33331 - Commercial
and Service Industry Machinery Manufacturing
UK SIC 2003: 3340 - Manufacture
of optical instruments and photographic equipment
US SIC 1987: 3827 - Optical
Instruments and Lenses
Key Executives
|
Name |
Title |
|
John R Ambroseo |
Director, President and Chief Executive
Officer |
|
Luis Spinelli |
Executive Vice President and Chief
Technology Officer |
|
Richard Waldermann |
Leiter-Betrieb |
|
Bret DiMarco |
Executive Vice President and General
Counsel |
|
Ronald A Victor |
Executive Vice President, Human Resources |
Registered No.(DEU): 4164
1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7397102
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.6841349
Corporate Overview
Location
Hans-Bockler-Strasse 12
Gottingen, 37079
Germany
Tel: +49 (0) 551 69380
Fax: +49 (0) 551 68691
Web: www.coherent.de
Sales EUR(mil) 94.3
Assets EUR(mil): 119.6
Employees: 365
Fiscal Year End: 30-Sep-2009
Industry: Scientific and Technical Instruments
Incorporation Date: 06-Jul-2005
Company Type: Private Subsidiary
Quoted Status: Not Quoted
Registered No.(DEU): 4164
Leiter-Betrieb: Richard Waldermann
Contents
· Industry Codes
· Business Description
· Financial Data
· Subsidiaries
· Key Corporate Relationships
Industry Codes
ANZSIC 2006 Codes:
2419 - Other Professional and Scientific Equipment Manufacturing
NACE 2002 Codes:
3340 - Manufacture of optical instruments and photographic
equipment
3320 - Manufacture of instruments and appliances for measuring,
checking, testing, navigating and other
purposes, except
industrial process control equipment
NAICS 2002 Codes:
33331 - Commercial and Service Industry Machinery Manufacturing
334513 - Instrument's and Related Products Manufacturing for
Measuring, Displaying, and Controlling Industrial Process Variable
US SIC 1987:
3827 - Optical Instruments and Lenses
3823 - Industrial Instruments for Measurement, Display, and
Control of Process Variables; and Related Products
UK SIC 2003:
3340 - Manufacture of optical instruments and photographic
equipment
3320 - Manufacture of instruments and appliances for measuring,
checking, testing, navigating and other purposes, except industrial process
control equipment
Business Description
Coherent GmbH is primarily engaged in manufacture of spectacles and
unmounted lenses; manufacture of optical precision instruments; manufacture of
photographic and cinematographic equipment.
More Business
Descriptions
In the highly
sophisticated industry of photonics, Coherent leads the way, offering
reliability, cost, and performance advantages for the widest range of
commercial and scientific research applications. Founded in 1966, Coherent has
production and research facilities spanning the world, supplying everything
from laser systems and components to laser measurement and control products and
precision optics to over 80 countries. Notably, many of its customers are
Fortune 500 leading manufacturers and scientific researchers from numerous universities
and institutes across the Americas, Europe, and Pacific Rim. Markets for
Coherent's products include microelectronics (which includes semiconductor test
and measurement, flat panel display manufacturing, and advanced packaging),
scientific research and government programs, materials processing, OEM
components and instrumentation (which includes such areas as biotechnology,
medical imaging and treatment), and graphic arts and display.
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
Corporate Family |
Corporate
Structure News: |
|
|
|
|
Total Corporate Family Members: 2 |
|
|
Company Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Parent |
Dieburg, Hessen |
Germany |
Commercial Banks |
|
3 |
|
|
|
Subsidiary |
Göttingen, Niedersachsen |
Germany |
Scientific and Technical Instruments |
127.5 |
365 |
|
Executive report
|
Board of Directors |
|
|
|
|
|||
|
Independent Director and Chairman-Board Committee |
Chairman |
|
|||
|
Director |
Director/Board Member |
|
|||
|
Director |
Director/Board Member |
|
|||
|
Director |
Director/Board Member |
|
|
Executives |
|
|
|
|
|||
|
Director, President and Chief Executive Officer |
Chief Executive Officer |
|
|||
|
Leiter-Betrieb |
Operations Executive |
|
|||
|
Executive Vice President, Human Resources |
Human Resources Executive |
|
|||
|
Executive Vice President and Chief Technology Officer |
Information Executive |
|
|||
|
Executive Vice President and General Counsel |
Legal Executive |
|
Annual Profit & Loss
|
|
30-Sep-2009 |
30-Sep-2008 |
30-Sep-2007 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate (Period
Average) |
0.73971 |
0.666382 |
0.752073 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Total income |
127.5 |
184.8 |
177.0 |
|
Raw materials and services |
44.7 |
71.8 |
77.1 |
|
Net sales |
127.5 |
184.8 |
177.0 |
|
Change in stock |
-0.8 |
-2.6 |
2.3 |
|
Own work capitalised |
0.1 |
0.4 |
0.3 |
|
Other operating income |
4.0 |
10.9 |
2.7 |
|
Raw materials and consumables employed |
44.7 |
71.8 |
77.1 |
|
Cost of goods sold |
44.7 |
71.8 |
77.1 |
|
Cost of raw materials |
44.7 |
71.8 |
77.1 |
|
Taxes and social security costs |
4.7 |
6.5 |
6.0 |
|
Total payroll costs |
32.9 |
43.7 |
39.4 |
|
Fixed asset depreciation and amortisation |
5.5 |
7.1 |
6.6 |
|
Other operating costs |
45.4 |
73.2 |
58.5 |
|
Net operating income |
25.2 |
34.3 |
30.1 |
|
Other income |
1.4 |
3.8 |
3.4 |
|
Interest payable on loans |
0.0 |
0.1 |
0.7 |
|
Total expenses |
-1.3 |
-3.6 |
-2.6 |
|
Profit before tax |
26.5 |
38.0 |
32.7 |
|
Provisions |
12.4 |
26.1 |
22.9 |
|
Other taxes |
0.1 |
0.2 |
0.1 |
|
Total taxation |
6.7 |
8.7 |
5.9 |
|
Net profit |
19.7 |
29.1 |
26.7 |
Annual Balance Sheet
Financials in: USD
(mil)
|
|
30-Sep-2009 |
30-Sep-2008 |
30-Sep-2007 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.684135 |
0.711921 |
0.703161 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
- |
18.7 |
18.9 |
|
Capital reserves |
- |
119.1 |
165.8 |
|
Other reserves |
- |
4.7 |
4.7 |
|
Total reserves |
- |
4.7 |
4.7 |
|
Profits for the year |
- |
-8.7 |
-36.4 |
|
Profit brought forward from previous year(s) |
- |
-35.9 |
-64.9 |
|
Total stockholders equity |
157.3 |
133.8 |
153.1 |
|
Deferred taxation |
2.2 |
5.5 |
5.5 |
|
Other provisions |
11.0 |
18.8 |
18.9 |
|
Provision for pensions |
0.2 |
0.1 |
0.2 |
|
Provisions and allowances |
13.4 |
24.4 |
24.5 |
|
Trade accounts payable |
0.0 |
- |
- |
|
Taxes and social security |
0.1 |
- |
- |
|
Total long-term liabilities |
0.1 |
0.1 |
- |
|
Trade creditors |
3.0 |
- |
3.3 |
|
Taxation and social security |
0.8 |
- |
1.0 |
|
Due to group companies |
0.2 |
- |
0.2 |
|
Total current liabilities |
4.0 |
4.1 |
4.4 |
|
Total liabilities (including net worth) |
174.8 |
162.4 |
182.0 |
|
Patents |
0.3 |
0.5 |
0.3 |
|
Goodwill |
1.0 |
1.4 |
1.9 |
|
Intangibles |
1.3 |
1.9 |
2.2 |
|
Land and buildings |
15.6 |
15.6 |
18.0 |
|
Fixtures and equipment |
15.6 |
15.6 |
18.0 |
|
Fixed assets under construction |
0.4 |
1.7 |
1.9 |
|
Total tangible fixed assets |
29.2 |
31.5 |
34.0 |
|
Long-term investments |
0.0 |
0.0 |
0.0 |
|
Shares held in associated companies |
- |
0.1 |
0.1 |
|
Total financial assets |
0.0 |
0.1 |
0.1 |
|
Total non-current assets |
30.5 |
33.4 |
36.3 |
|
Raw materials |
- |
10.1 |
11.3 |
|
Work in progress |
- |
9.6 |
9.9 |
|
Finished goods |
- |
5.3 |
7.7 |
|
Prepayments |
- |
0.0 |
0.1 |
|
Net stocks and work in progress |
- |
25.0 |
28.9 |
|
Trade debtors |
- |
0.1 |
- |
|
Other receivables |
- |
2.2 |
1.6 |
|
Total receivables |
- |
29.6 |
33.0 |
|
Owing from associated companies |
- |
27.3 |
31.4 |
|
Cash and liquid assets |
- |
74.3 |
83.8 |
|
Total current assets |
144.3 |
128.9 |
145.7 |
|
Prepaid expenses and deferred costs |
0.0 |
0.0 |
0.0 |
|
Total assets |
174.8 |
162.4 |
182.0 |
Annual Ratios
Financials in: USD (mil)
|
|
30-Sep-2009 |
30-Sep-2008 |
30-Sep-2007 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.684135 |
0.711921 |
0.703161 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
- |
310.72 |
327.91 |
|
Acid test ratio |
- |
250.40 |
262.89 |
|
Total liabilities to net worth |
0.00% |
0.00% |
0.00% |
|
Net worth to total assets |
0.09% |
0.08% |
0.08% |
|
Current liabilities to net worth |
0.00% |
0.00% |
0.00% |
|
Current liabilities to stock |
- |
0.02% |
0.02% |
|
Fixed assets to net worth |
0.02% |
0.03% |
0.02% |
|
Collection period |
- |
4.00 |
- |
|
Stock turnover rate |
- |
1.45 |
1.53 |
|
Profit margin |
0.02% |
0.02% |
0.02% |
|
Return on assets |
0.01% |
0.02% |
0.02% |
|
Shareholders' return |
0.01% |
0.02% |
0.02% |
|
Sales per employee |
19.53 |
23.87 |
25.35 |
|
Profit per employee |
3.01 |
3.76 |
3.82 |
|
Average wage per employee |
5.04 |
5.64 |
5.64 |
|
Net worth |
157.3 |
133.8 |
153.1 |
|
Number of employees |
483 |
516 |
525 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.05 |
|
UK Pound |
1 |
Rs.75.20 |
|
Euro |
1 |
Rs.66.48 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.